Health

NASA/CXC/MIT/
F.K.Baganoff et al.

Global vaccines market forecast to grow to $34 billion by 2012   "Vaccines have emerged as one of the most lucrative segment in the global pharmaceutical industry, according to a new report added to the offering of Research and Markets. Overall, the global vaccine market is expected to register revenues in excess of $34 billion by 2012. With a projected compound annual growth rate (CAGR) of over 13% during 2009-2012, the industry will emerge as the fastest growing therapy area. The US and Europe represent the two largest global vaccine markets and will continue experiencing healthy growth rate in future. .." thepharmaletter.com (site accessed Dec 09)

Stem cell treatment for sight loss could be in use by 2012  "A Stem cell treatment for the leading cause of sight loss in older people could be in widespread use within six years, according to researchers. The Edinburgh Science Festival will later this week hear that scientists want to start patient trials of the treatment for age-related macular degeneration (AMD) by 2012 ..." news.scotsman.com (site accessed April 2009)

One in three Britons may be obese by 2012   "...A third of all British adults -- some 13 million people -- will be obese by 2012 if current trends continue, jeopardising their health and straining healthcare budgets ... Almost half of them will be from low income and disadvantaged communities, widening the health gap between the haves and have-not ..." reuters.com (site accessed Dec 08)
See also:
Europe: Obesity to hit one third of kids by 2012   "Over a third of children aged five to 13 will be overweight or obese by 2012, according to a report published today (7 July) by research analysts Datamonitor ... Datamonitor blamed above-average consumption of "energy-dense, indulgence food and drinks", including savoury snacks and ice cream. The analysts also pointed to non-food factors including lack of exercise and the importance of travelling by car to out-of-town retail parks and leisure venues ..." just-food.com (site accessed July 2008)

Malaria vaccine may be available in 2012   "A vaccine against the parasitic disease malaria cut illnesses by more than half in field trials and could be safely given with other childhood inoculations, two studies have reported. The vaccine, which will begin a third and final phase of clinical trials early next year, could become the first to protect children from malaria, which kills nearly 1 million people worldwide every year ..." latimes.com (site accessed Dec 2008)

Death from HIV/AIDS to peak in 2012  "The number of deaths due to HIV and AIDS is expected to peak in 2012, according to a report released by the World Health Organization. In its new Global Burden of Disease publication on Monday, the UN health agency expects deaths caused by HIV and AIDS to rise from 2.2 million in 2008 to a maximum of 2.4 million in 2012, before declining to 1.2 million in 2030 ..." xinhuanet.com (site accessed Oct 08)
See also: Therapeutic vaccine for Aids by 2012   "A French scientist awarded the Nobel Prize for medicine for discovering the AIDS virus immediately predicted there would be a "therapeutic vaccine" for the disease within four years ... A therapeutic vaccine prevents disease from flourishing after it has taken hold ..." telegraph.co.uk (site accessed Oct 08)
See also: HIV experts say 20 million in Asia could be infected by 2012   "The number of people in Asia with the AIDS virus may more than double over the next five years unless governments do more to stop the spread of HIV, officials said yesterday. About 8.6-million people in Asia are infected with HIV..." The Calgary Sun (site accessed Apr 2007)
See also: 500,000 people in Uganda to be targeted for routine AIDS testing and counselling by 2012   "... Currently, there are an estimated 1.1 million HIV infected individuals and this number is projected to increase to 1.8 million by 2012 at the current rate of of 135,000 new infections annually ...” NewVision.co.ug (site accessed Jan 2007)

China's Hepatitis B market to double by 2012   " ... Decision Resources puts the current count of people in China with chronic hepatitis B at 80 million, though other reports estimate the total is 50% higher – 120 million. That constitutes almost 10% of the population. Part of the reason behind the high dollar value of drugs for this population is that the nucleoside/nucleotide analogue class of drugs often used to treat the disease must be given long term, often for the rest of a patient’s life. In most cases, these drugs are effective, suppressing the viral count, but the disease reappears as soon as treatment is discontinued ..." seekingalpha.com (site accessed Sep 2008)

USA: Nutritional supplements to reach $8.5 billion in 2012   " ... Helping to protect the category as consumers tighten their discretionary spending belts are the strong preventive health care angle of supplements and the market’s sizeable component of better-off demographics including aging Baby Boomers. Nutritional Supplements in the U.S. reports on numerous other positive factors also at play, including industry efforts to promote supplements as more essential than ever in weak economic times since they can help to avert the need for much costlier prescription drugs and medical treatments ..." packagedfacts.com (site accessed Aug 08)

Global market for cancer drugs expected to exceed $78 billion by 2012   " ... Cancer vaccines and antiangiogenics will record the fastest growth rate between 2007 and 2012 ..." researchandmarkets.com (site accessed Aug 2008)
See also: $8 billion dollar cancer vaccine market by 2012   " ... As many as five new vaccines to treat cancer may soon be available, creating an $8 billion dollar cancer vaccine market by 2012, representing over half of the $15 billion total vaccine market that will exist that year, according to (market research firm) Kalorama. ...." Earthtimes.org (site accessed Feb 2007)
See also: Global Market for Cancer Immunotherapy Worth $37.2 Billion by 2012 Pharmalive.com (site accessed Mar 2007)

Gastrointestinal disorders in 2012   "Gastrointestinal (GI) disorders are set to affect over 250 million people in the seven largest pharma markets, by 2012. As generations of people become more obese and consume increasingly poor diets then so too will the number of people suffering from these disorders rise ... " expertdoctor.blogspot.com (site accessed Sep 2007)

Global epigenomics market to reach $4.1 billion by 2012  "$4.1 Billion by 2012? is the major finding of a market report on the global epigenomics market published by BCC Research. The report identified three key market segments that will be commercially important in the field of epigenomics in the next 5 years: research tools, cancer diagnostics, and cancer therapeutics." www.epigeneticsnews.com (site accessed May 2007)

South Korea will start to use human embryonic stem cells in actual therapy around 2012   "The first target will be hard-to-cure diseases caused by nerve cell disorders as scientists are continuing to make breakthroughs in the field'' The Korea Times (site accessed Sept 2006)

NHS Computer system to link general practitioners (GPs) in England to nearly 300 hospitals by 2012   "It involves an online booking system, a centralised medical records system for 50m patients, e-prescriptions and fast computer network links between NHS organisations ....senior academics question whether the National Programme for IT has been properly designed and rigorously reviewed to meet the needs of 24-hour health care." BBC News (site accessed June 2006)

Worldwide homecare systems expected to reach $1.2 billion by 2012 "The homecare market is changing. New services needed in the home include intravenous (IV) therapy, pain control, and basic needs services delivery. Delivery of new services depends on systems integration." Genetic Engineering News (site accessed May 2006)

Transgenically Produced Biopharmaceuticals Could Soar to $12 Billion by 2012
"With the possibility of the world’s first transgenic plant-produced biopharmaceutical being approved for use this year, worldwide attention is focusing on the futuristic breakthroughs that could dramatically alter the biopharm manufacturing landscape and drive sales past the $12 billion mark by 2012, according to a new study from market research firm Kalorama Information, a division of MarketResearch.com, a leading provider of industry-specific market research reports." PR Leap (site accessed Feb 2006)

China vows to eliminate measles by 2012   "China is drafting an action plan for measles control for the next few years which aims to eliminate measles by 2012." China View (site accessed Mar 2006)
See also: The Chinese government has drawn up a 5 yr action plan to eliminate measles. China View (site accessed Dec 2006)

top